Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | protein kinase C, alpha | No references | |
Homo sapiens | protein kinase C, theta | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | protein kinase C gamma type | 0.0072 | 0.2969 | 0.7495 |
Toxoplasma gondii | AGC kinase | 0.0023 | 0.003 | 0.5 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.0023 | 0.003 | 0.5 |
Echinococcus multilocularis | serine threonine protein kinase | 0.0072 | 0.2969 | 0.7495 |
Entamoeba histolytica | protein kinase, putative | 0.0023 | 0.003 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 0.861 | 0.8606 |
Brugia malayi | Protein kinase c protein 2 | 0.0066 | 0.2592 | 1 |
Schistosoma mansoni | atypical protein kinase C | 0.004 | 0.1012 | 0.2505 |
Loa Loa (eye worm) | AGC/PKC/ALPHA protein kinase | 0.005 | 0.161 | 0.1584 |
Entamoeba histolytica | protein kinase, putative | 0.0023 | 0.003 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.1489 | 0.1463 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 0.861 | 0.8606 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0089 | 0.3952 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0089 | 0.3952 | 1 |
Echinococcus granulosus | Protein kinase C brain isozyme | 0.0089 | 0.3952 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 0.861 | 0.8606 |
Trichomonas vaginalis | AGC family protein kinase | 0.0023 | 0.003 | 1 |
Echinococcus multilocularis | Protein kinase C, brain isozyme | 0.0089 | 0.3952 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0041 | 0.1103 | 0.2736 |
Trichomonas vaginalis | AGC family protein kinase | 0.0023 | 0.003 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0023 | 0.003 | 1 |
Onchocerca volvulus | 0.0167 | 0.861 | 0.5 | |
Echinococcus granulosus | protein kinase c epsilon type | 0.0041 | 0.1103 | 0.2736 |
Entamoeba histolytica | protein kinase, putative | 0.0023 | 0.003 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0023 | 0.003 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0064 | 0.2471 | 0.2449 |
Echinococcus multilocularis | protein kinase c iota type | 0.004 | 0.1012 | 0.2505 |
Trichomonas vaginalis | AGC family protein kinase | 0.0023 | 0.003 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0023 | 0.003 | 1 |
Loa Loa (eye worm) | AGC/PKC/ETA protein kinase | 0.0041 | 0.1103 | 0.1076 |
Trichomonas vaginalis | AGC family protein kinase | 0.0023 | 0.003 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0023 | 0.003 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0023 | 0.003 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0023 | 0.003 | 1 |
Echinococcus multilocularis | telomerase reverse transcriptase subunit | 0.0048 | 0.1489 | 0.372 |
Loa Loa (eye worm) | hypothetical protein | 0.0183 | 0.9593 | 0.9592 |
Echinococcus granulosus | protein kinase c iota type | 0.004 | 0.1012 | 0.2505 |
Echinococcus granulosus | RNA directed DNA polymerase | 0.0048 | 0.1489 | 0.372 |
Entamoeba histolytica | protein kinase, putative | 0.0023 | 0.003 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0023 | 0.003 | 1 |
Echinococcus multilocularis | RNA directed DNA polymerase | 0.0048 | 0.1489 | 0.372 |
Echinococcus multilocularis | protein kinase c epsilon type | 0.0041 | 0.1103 | 0.2736 |
Brugia malayi | protein kinase C II. | 0.0041 | 0.1103 | 0.4188 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 1 nM | In Vitro Inhibition Activity Assay | BINDINGDB. | No reference |
IC50 (binding) | = 32 nM | In Vitro Inhibition Activity Assay | BINDINGDB. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.